Clinical Trials Directory

Trials / Unknown

UnknownNCT04419948

Oleocanthal Rich Olive Oil Acute Effects on Hyperglycemia and Platelet Activation in T2DM

Acute Effect of Oleocanthal Rich Extra-virgin Olive Oil on Postpranial Hyperglycemia and Platelet Activation of T2DM Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Harokopio University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a pilot acute dietary intervention study with a randomized cross-over design aiming to investigate whether acute supplementation of extra virgin olive oil (EVOO) rich in oleocanthal could attenuate postprandial hyperglycemia and activation of platelets in T2DM patients. For this reason, non-insulin dependent diabetic patients (10-15) will be randomly assigned to consume in five different days white bread (50 g CHO) with butter, butter with ibuprofen, refined olive oil and olive oil with oleocanthal (250 mg/Kg 500 mg/Kg). Blood samples will be collected pre- and post-intervention up to 4 hours in order to determine platelet aggregation, postprnadial glycemia, lipemia, inflammation and oxidative stress. Taking into account the strong anti-inflammatory and anti-platelet properties of oleocanthal, this study will assess whether oleocanthal-rich olive oils could exert similar effects under real in vivo conditions in T2DM patients. It will also assess whether these effects are achieved through improvement of postprandial glycemia and lipemia.

Conditions

Interventions

TypeNameDescription
OTHERWhite breadWhite bread (120g) containing 54 g CHO
OTHERButterButter 39 g
OTHERRefined olive oilRefined olive oil (40 ml).
OTHEREVOO with 250 mg/kg oleocanthalExtra virgin olive oil containing 250 mg/kg oleocanthal.
OTHEREVOO with 500 mg/kg oleocanthalExtra virgin olive oil containing 500 mg/kg oleocanthal.
OTHERIbuprofenIbuprofen 400 mg

Timeline

Start date
2019-05-16
Primary completion
2020-12-01
Completion
2021-07-01
First posted
2020-06-09
Last updated
2020-06-09

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT04419948. Inclusion in this directory is not an endorsement.